The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Traditional Korean Medicine Treatment for Sequelae After Surgery in Prostate Cancer Patients: Two Case Report

전립선암환자의 수술 후 발생한 후유증에 대한 한방치료 2례

  • Jang, Kwon-jun (Jangdeuk Korean Medicine Hospital) ;
  • Yang, Jung-min (Jangdeuk Korean Medicine Hospital) ;
  • Hwang, Woo-seok (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Beom-joon (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University)
  • 장권준 (장덕한방병원) ;
  • 양정민 (장덕한방병원) ;
  • 황우석 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 이범준 (경희대학교대학원 임상한의학과 폐계내과학교실)
  • Received : 2022.08.22
  • Accepted : 2022.10.27
  • Published : 2022.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study is to report two cases of prostate cancer patients whose side effects after surgery were treated with traditional Korean medicine. Methods: Two prostate cancer patients underwent robot-assisted laparoscopic prostatectomy, and both patients were treated with traditional Korean medicine. Subjective discomfort symptoms were evaluated using the Numerical Rating Scale. Adverse events were evaluated using the National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0. Daily life vitality was evaluated by the Eastern Cooperative Oncology Group. Results: After treatment with traditional Korean medicine, discomfort symptoms that occurred after surgery, such as frequent urination, nocturia, insomnia, and depression, all gradually improved, and Eastern Cooperative Oncology Group scores also improved from two points to one point. Additionally, there were no hematologic side effects from the traditional Korean medicine treatment. Conclusions: This case study suggests that traditional Korean medicine may contribute to the improvement of side effects caused by robot-assisted laparoscopic prostatectomy, quality of life, and immunity.

Keywords

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63(1):11-30. https://doi.org/10.3322/caac.21166
  2. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61(6):1079-92. https://doi.org/10.1016/j.eururo.2012.02.054
  3. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019. Cancer Res Treat 2022;54(2):330-44. https://doi.org/10.4143/crt.2022.128
  4. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17(6):1471-4. https://doi.org/10.1245/s10434-010-0985-4
  5. Network NCC. NCCN clinical practice guidelines in oncology; prostate cancer. Version 1.2014. NCCN.org; 2014, p. 7-17.
  6. Lilleby W, Fossa SD, Waehre HR, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999;43(4):735-43. https://doi.org/10.1016/S0360-3016(98)00475-1
  7. Yang BK, Young MD, Calingaert B, Albala DM, Vieweg J, Murphy BC, et al. Prospective and longitudinal patient self-assessment of health-related quality of life following radical perineal prostatectomy. J Urol 2004;172(1):264-8. https://doi.org/10.1097/01.ju.0000128775.27331.d7
  8. Aikawa K, Yamaguchi O, Oguro T, Ishibashi K, Yanagida T, Nomiya M, et al. New classification for men with lower urinary tract symptoms: cluster analysis using the International Prostate Symptom Score. BJU Int 2012;110(3):408-12. https://doi.org/10.1111/j.1464-410X.2011.10771.x
  9. Song BK, Lee EJ, Yoo HS. Clinical Practice Guideline on Prostate Cancer in Korean Medicine. Journal of Korean traditional oncology 2016;21(2):1-35. https://doi.org/10.15432/JKTO.2016.21.1.001
  10. Cao H, Mu Y, Li X, Wang Y, Chen S, Liu JP. A Systematic Review of Randomized Controlled Trials on Oral Chinese Herbal Medicine for Prostate Cancer. PLOS ONE 2016;11(8):e0160253. https://doi.org/10.1371/journal.pone.0160253
  11. Common Terminology Criteria for Adverse Events (CTCAE). National Cancer Institute. Available from: URL:https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Published 2020. Accessed August 14, 2020.(CTCAE) v5.0.2020.
  12. Koh M, Kim YS, Ahn H, Kim CS. Patterns of Recurrence After Salvage Radiotherapy Encompassing Pelvic Lymphatics in Men with High-risk Prostate Cancer. Anticancer Res 2018;38(11):6579-84. https://doi.org/10.21873/anticanres.13025
  13. Devita VT, Lawrence TS, Rosenberg SA. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 11th Edition. School of Medicine; 2018, p. 186-95.
  14. Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF. Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int 2013;111(2):213-20. https://doi.org/10.1111/j.1464-410X.2012.11423.x
  15. Wallace M. Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum 2003;30(2):303-9. https://doi.org/10.1188/03.ONF.303-309
  16. Bailey Jr DE, Wallace M, Mishel MH. Watching, waiting and uncertainty in prostate cancer. Journal of Clinical Nursing 2007;16(4):734-41. https://doi.org/10.1111/j.1365-2702.2005.01545.x
  17. Nam KH, Tae YS, Kim CS, Lee SM. Influence of Uncertainty and Uncertainty Appraisal on Quality of Life in Prostate Cancer Patients after Prostatectomy. Asian Oncology Nursing 2017;17(1):45-54. https://doi.org/10.5388/aon.2017.17.1.45
  18. 庞然, 高筱松, 卢建新, 刘兵, 宋竖旗, 薄海, et al. 前列消癥汤治疗激素难治性前列腺癌临床观察. 北京中医药 2010;29(2):918-9.
  19. 庞然, 卢建新, 高筱松, 刘兵, 宋竖旗, 薄海. 前列 消癥汤治疗激素难治性前列腺癌的临床研究. 中国中西医结合外科杂志 2013;19(4):374-7.
  20. 吴燕敏, 马国花, 魏睦新. 知柏地黄汤加味治疗早期前列腺癌 38 例. 时珍国医国药 2009;20:951-2.
  21. 林洪生. 惡性腫瘤中医診療指南. 北京: 人民衛生出版社; 2014, p. 499-515.
  22. Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integrative cancer therapies 2010;9(4):331-8. https://doi.org/10.1177/1534735410383170
  23. 강영수. 임상배합본초학. 서울: 영림사; 1994, p. 307-8.
  24. Lim DS, Kim EJ, Lee DW, Cho SI. The Antistress Effects of Semen Spinosae Extract. J of Oriental Neuropsychiatry 2003;14(1):107-16.
  25. 황도연. 방약합편. 서울: 남산당; 1986, p. 166-8.
  26. 余绍龙, 陈智锋, 林峰, 黄小琴, 温志鹏, 王炎 et al. 六味地黄汤联合内分泌治疗晚期前列腺癌的临床观察. 中国当代医药 2010;17(2):93.
  27. 李載熙. 圖說 漢方診療要方. 강원: 醫方出版社; 2004, p. 118-9.
  28. 辛民敎. 臨床本草學. 서울: 圖書出版 永林社; 2022, p. 622-3.
  29. Beer TM, Benavides M, Emmons SL, Hayes M, Liu G, Garzotto M, et al. Acupuncture for hot flashes in patients with prostate cancer. Urology 2010;76(5):1182-8. https://doi.org/10.1016/j.urology.2010.03.033
  30. Yoo HS, Cho JH, Choi CK. Effects of Herbal Acupuncture(Soyeum) on Cancer Patients Accompanied by Pain. J of Korean pharmacopuncture institute 2003;6(1):16-7 https://doi.org/10.3831/KPI.2003.6.1.016